Validation of a new serum granulocyte–macrophage colony-stimulating factor autoantibody testing kit
Very recently, a modest but significant efficacy of granulocyte–macrophage colony-stimulating factor (GM-CSF) inhalation therapy for the treatment of mild to moderate autoimmune pulmonary alveolar proteinosis (aPAP) has been reported. As the ability to measure the level of GM-CSF autoantibody (GMAb)...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Respiratory Society
2020-01-01
|
Series: | ERJ Open Research |
Online Access: | http://openres.ersjournals.com/content/6/1/00259-2019.full |